In acinetobacter baumannii is immobile, aerobic, gramnegative short rods with a size of about 11. Identification of potential common sources of an outbreak, through surveillance cultures and epidemiological typing. Treatment of acinetobacter infections clinical infectious diseases. A pmrbregulated deacetylase required for lipid a modification and polymyxin resistance in acinetobacter baumannii. In recent news, an antibioticresistant strain of a. It is a frequent cause of pneumonia and septicemia in immunocompromised patients. The diagnosis of acinetobacter infection is made by the growth of acinetobacter from a patient specimen eg, sputum, blood, cerebrospinal fluid in the setting of other clinical findings that suggest an infection at that site. Current control and treatment of multidrugresistant.
Clinical antibioticresistant acinetobacter baumannii. Since acinetobacter colonization is common and treatment difficult and potentially associated with substantial toxicity, the distinction between colonization and. An acinetobacter baumannii infection is caused by the acinetobacter baumannii bacteria germ. Polymyxins are often lastline therapeutic agents used to treat infections caused by multidrugresistant a.
Under the microscope, it looks halfway between a rod and a ball. Acinetobacter baumannii has proven to be an increasingly important and demanding species in health careassociated infections. The present study was focused on evaluate biofilm, pellicle formation, gelatinase activity, bacteriocin. Acinetobacter baumannii is found only rarely as part of the normal skin microflora, with one study estimating that only 3% at most of the population are colonized by the bacterium.
The importance of guidelines in the development and application of probiotics. Antimicrobial agents for the treatment of acinetobacter infections. The drugresistant nature of the pathogen and its unusual and unpredictable susceptibility patterns make empirical and therapeutic decisions even more difficult. It can also colonize or live in a patient without causing infections or symptoms, especially in respiratory secretions sputum or open wounds. Summary acinetobacter baumannii has emerged as a highly troublesome pathogen for many institutions globally. Acinetobacter baumannii infection what you need to know. Carbapenemresistant acinetobacter baumannii in healthcare. Survival of acinetobacter baumannii on dry surfaces. It can be spread by direct contact and may be found on skin or in food, water, or soil. Acinetobacter baumannii an overview sciencedirect topics.
Successful treatment of extensively drugresistant acinetobacter. Antimicrobial susceptibility of acinetobacter baumannii. Acinetobacter baumannii can cause infections in the blood, urinary tract, and lungs pneumonia, or in wounds in other parts of the body. While there are many types or species of acinetobacter and all can cause human disease, acinetobacter baumannii accounts for about 80% of reported infections. It can cause serious infections in the lungs, blood, and brain. The recent increase in incidence, largely associated with infected combat troops returning from conflict zones, coupled with a dramatic increase in the incidence of multidrugresistant mdr strains. It can be an opportunistic pathogen in humans, affecting people with compromised immune systems, and is becoming increasingly important as a hospitalderived infection. Heres what you need to know to prevent these infections. The acinetobacter superbug can cause diseases such as pneumonia and meningitis. Americas clinical practice guidelines for healthcareassociated ventriculitis. Acinetobacter species assigned to the acinetobacter calcoaceticusbaumannii acb complex, are gramnegative bacteria responsible for a large number of human infections. The challenge for the clinician is to combine local susceptibility patterns with the. An acinetobacter baumannii infection is caused by the acinetobacter baumannii bacteria.
Pdf institutional outbreaks caused by acinetobacter baumannii strains that have. Acinetobacter species belong to a group of gramnegative bacteria that are readily found throughout the environment including drinking and surface waters, soil, sewage and various types of foods. Healthcare provider information sheet for multidrugresistant acinetobacter baumannii mdrab division of infectious disease epidemiology dide 350 capitol street, room 125, charleston, wv 2530715 phone. Resistance to antimicrobials including colistin epidemiology of microorganism including survival of a.
Notably, imipenem treatment of the imipenemresistant a. Effective antibiotic treatment of a baumannii infections, such as. Acinetobacter is a gramnegative coccobacillus figure 11,2 that during the past three decades has emerged from an organism of questionable pathogenicity to an infectious agent of importance to ho. A number of studies have reported promising results regarding the efficacy of sulbactam against a. Acinetobacter baumannii is emerging infectious diseases resistant to several antibiotics early diagnosis and optimal treatment can reduce morbidity and mortali. Acinetobacter baumannii is a topic covered in the johns hopkins abx guide to view the entire topic, please sign in or purchase a subscription official website of the johns hopkins antibiotic abx, hiv, diabetes, and psychiatry guides, powered by unbound medicine. Acinetobacter species can acquire resistance genes from other. Acinetobacter baumannii is one of the escape organisms, a group of. Comparative analysis of the two acinetobacter baumannii. Antimicrobial susceptibility of acinetobacter baumannii isolated from hospital patients wanutsanun tunyapanit a. Acinetobacter baumannii remains an important and difficulttotreat pathogen whose. Decisions on treatment of infections with acinetobacter should be made on a casebycase basis by a healthcare provider. This germ may be found on skin or in food, water, or soil. Management of multidrugresistant acinetobacter spp.
Drug treatment for multidrugresistant acinetobacter. Acinetobacter baumannii remains an important and difficulttotreat pathogen whose resistance patterns result in significant challenges for the clinician. Acinetobacter baumannii is a typically short, almost round, rodshaped coccobacillus gramnegative bacterium. This case report describes an outbreak of multidrug resistant acinetobacter baumannii in the intensive care unit of a tertiary care hospital. Acinetobacter baumannii is a bacterium that can cause a range of diseases.
Acinetobacter baumannii is a pleomorphic aerobic gramnegative bacillus similar in appearance to haemophilus influenzae on gram stain commonly isolated from the hospital environment and hospitalized patients. Acinetobacter fact sheet utah department of health. Evolution of antimicrobial resistancetreatment options yohei doi, md, phd1 gerald l. Structural insights into outer membrane permeability of. It may also cause urinary tract and wound infections. Apart from its predilection for the seriously ill within intensive care units, a. Drugresistant acinetobacter healthcare setting fact sheet. Optimal therapy for multidrugresistant acinetobacter. Due to the prevalence of infections and outbreaks caused by multidrug resistant a. Habitat and morphology of acinetobacter baumannii online. As a consequence of its immense ability to acquire or upregulate antibiotic drug resistance determinants, it has justifiably been propelled to the forefront of scientific attention. Acinetobacter bacteria can also be found on the skin of healthy people, especially healthcare personnel. Acinetobacter baumannii specifically targets moist tissues such as mucous membranes or areas of the skin that are exposed, either through accident or injury. Because of complex epidemiology, infection control of these outbreaks is difficult to attain.
Update on the epidemiology, treatment, and outcomes of. The recent increase in incidence, largely associated with infected combat troops returning from conflict zones, coupled with a dramatic increase in the incidence of multidrugresistant mdr strains, has significantly raised the profile of this emerging opportunistic pathogen. Consulted experts internal experts consulted in alphabetical order. Acinetobacter baumannii is undoubtedly one of the most successful pathogens responsible for hospitalacquired nosocomial infections in the modern healthcare system. Three patients were infected on the same day from an. To overcome this problem, knowledge of the pathogenesis. The population structure of acb has been studied using two 7gene mlst schemes, introduced by bartual and coworkers oxford scheme and by diancourt and coworkers pasteur scheme. The circumstances of some outbreaks demonstrated the long survival of acinetobacter in a dry, inanimate environment. Antibiotic resistance in the gramnegative bacterium acinetobacter baumannii is caused in part by a lowpermeability outer membrane om. Acinetobacter baumannii is a gramnegative coccobacillus that has been listed as the most important pathogen in hospitals 1. Acinetobacter baumannii, a nonfermenter gramnegative coccobacillus, was considered a lowcategory pathogen in the past, but has now emerged as a leading cause of hospital and communityacquired infections.
Acinetobacter baumannii is an important causative agent of nosocomial infections, and carbapenems have been frequently used in the treatment of these. Acinetobacter baumannii can cause serious infections in the lungs, blood, and brain. Acinetobacter baumannii infection aftercare instructions. Acinetobacter baumannii is an opportunistic bacterial pathogen primarily associated with hospitalacquired infections. Multidrugresistant acinetobacter baumannii is recognized to be. Pdf current control and treatment of multidrugresistant. Institutional outbreaks caused by acinetobacter baumannii strains that have acquired multiple mechanisms of antimicrobial drug resistance constitute a growing publichealth problem. Peleg,mbbs,phd,mph,fracp2,3 1division of infectious diseases, department of medicine, university of pittsburgh school of medicine, pittsburgh, pennsylvania. Treatment acinetobacter is often resistant to many commonly prescribed antibiotics. Practice guidelines for the management of bacterial meningitis. Its ability to survive in a hospital milieu and its ability to persist for extended periods of time on surfaces makes it a frequent cause for healthcareassociated infections and it has led to multiple outbreaks. Acinetobacter baumannii has emerged in the last decades as a major cause of healthcareassociated infections.
408 946 870 646 1163 1335 1144 979 1371 102 1507 1137 155 1103 990 303 1021 1465 784 84 266 280 677 151 1011 336 776 644 635 1153 1284 167 211 102 1366 1311